Uploaded November 2026 | Updated November 2026, 3 days ago
The FDA is requiring new safety warnings for popular GLP-1 weight-loss medications over a potential increased risk of a rare eye condition.
The FDA is requiring new safety warnings for popular GLP-1 weight-loss medications over a potential increased risk of a rare eye condition.










